Clinical Trial Update: A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077) [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating letermovir (MK-8228) for cytomegalovirus prophylaxis in children and adolescents receiving a kidney transplant; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• PREVYMIS (letermovir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cytomegalovirus Prophylaxis | Phase 1 | Status: RECRUITING